BAC vs DHR: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Danaher Corporation โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Bank of America Corporation ยท Financial Services
$57.96
+15.7% upside to fair value
Med Conviction
Grade B
VS
Danaher Corporation ยท Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
BAC |
DHR |
| Current Price |
$57.96 |
$221.12 |
| Fair Value Estimate |
$67.08 |
$286.52 |
| Upside to Fair Value |
+15.7%
|
+29.6%
|
| Market Cap |
$411.3B |
$155.4B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
24.4x
|
24.8x
|
| Price / Sales |
2.1x
|
6.2x
|
| Price / FCF |
4.4x
|
28.5x
|
| Revenue Growth YoY |
+5.8%
|
+5.5%
|
| Gross Margin |
59.3%
|
58.5%
|
| Operating Margin |
22.5%
|
20.4%
|
| Return on Equity |
11.1%
|
7.7%
|
| Dividend Yield |
2.0% |
0.65% |
| FCF Yield |
22.88%
|
3.51%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Bank of America Corporation is a diversified U.S. money-center bank operating through Consumer Banking, Global Wealth & Investment Management, Global Banking, and Global Markets, serving roughly 67 million consumer and small business clients through about 4,200 retail financial centers and 16,000 ATMs as of the last detailed disclosure. The franchise quality is solid but not exceptional: TTM net โฆ
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is highโฆ
Accumulation Zones
| Metric |
BAC |
DHR |
| Zone Low |
$50.31 |
$214.89 |
| Zone High |
$57.02 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|